1. Home
  2. LULU vs VTRS Comparison

LULU vs VTRS Comparison

Compare LULU & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo lululemon athletica inc.

LULU

lululemon athletica inc.

HOLD

Current Price

$162.29

Market Cap

17.8B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$13.86

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LULU
VTRS
Founded
1998
1961
Country
Canada
United States
Employees
N/A
30000
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8B
17.2B
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
LULU
VTRS
Price
$162.29
$13.86
Analyst Decision
Hold
Buy
Analyst Count
25
4
Target Price
$190.26
$13.50
AVG Volume (30 Days)
2.6M
7.2M
Earning Date
06-04-2026
05-07-2026
Dividend Yield
N/A
3.45%
EPS Growth
N/A
N/A
EPS
13.26
N/A
Revenue
$11,102,600,000.00
$14,299,900,000.00
Revenue This Year
$5.52
$4.41
Revenue Next Year
$4.68
$1.96
P/E Ratio
$12.08
N/A
Revenue Growth
4.86
N/A
52 Week Low
$143.96
$7.39
52 Week High
$340.25
$16.47

Technical Indicators

Market Signals
Indicator
LULU
VTRS
Relative Strength Index (RSI) 49.62 52.37
Support Level $159.83 $12.90
Resistance Level $171.31 $16.38
Average True Range (ATR) 6.08 0.31
MACD 1.63 0.10
Stochastic Oscillator 74.11 86.67

Price Performance

Historical Comparison
LULU
VTRS

About LULU lululemon athletica inc.

Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 800 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 45 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: